A study carried out by Boehringer Ingelheim details patient experiences with idiopathic pulmonary fibrosis. This study was carried out over 500 people who had been diagnosed with the condition.

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to AbbVie’s venetoclax in combination with rituximab, in order to treat lymphocytic leukemia.

Health and medical groups are calling for the U.S. Department of Housing and Urban Development (HUD) to follow through with a proposal that would ban smoking in public housing facilities.

The Food and Drug Administration (FDA) Office of Women’s Health (OWH) has released a roadmap for research regarding women’s health, Deputy Director of Research Pamela Scott announced this week.

The American Academy of Family Physicians (AAFP) recently offered comments and recommendations relating to the 2016 draft of Prescribing Opioids for Chronic Pain from the U.S. Centers for Disease Control and Prevention (CDC).

A recent study funded by the National Institutes of Health (NIH) discovered a potential link to neurodegeneration through the brain’s waste disposal system.

Theresa Mullin, the director of Strategic Programs for the Food and Drug Administration (FDA), issued a statement on FDA Voice detailing the Patient-Focused Drug Development (PFDD) program and inviting patient organizations to participate.

Heart disease and stroke research has received funding through the recently passed spending bill. The National Institute of Neurological Disorders and Stroke will receive $91 million in financial support from the federal government, and the National Heart, Lung and Blood Institute will get $118 million.

The Food and Drug Administration announced this week that the indefinite deferral for blood donors based on sexual history has been modified. According to the announcement, this is similar to recommendations for what the FDA considers groups that are or were at greater risk for acquiring HIV, which includes those who have recently had a blood transfusion.

Website allows people to estimate medical costs under Affordable Care Act choices

The American Heart Association (AHA) released a report Monday on a study that indicated there is a potential link between pregnancy complications and greater risks of cardiovascular disease later in life. Researchers found that several pregnancy complications predicted the likelihood of heart-related issues, according to the study in the AHA journal Circulation.

Allergan has submitted an abbreviated new drug application with the U.S. Food and Drug Administration for its Carbidopia and Levodopa. These drugs are generic versions of Rytary, a drug developed by Impax Laboratories, and are meant to treat symptoms associated with Parkinson's disease, parkinsonism following carbon monoxide intoxication and post-encephalitic parkinsonism.

Merck unveiled an update to its portfolio of diabetes treatments on Thursday and provided information on a weekly treatment candidate for those with type 2 diabetes. Januvia is the company's primary medication in this area of treatment, approved for use in the U.S. in 2006 and now prescribed in approximately 127 countries.

Jardiance (empagliflozin), a medication for adults with Type 2 diabetes from Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Co., was found to reduce the risk of a fatal cardiovascular event and stroke, the pharmaceutical companies announced Thursday.

Bristol-Myers Squibb received Breakthrough Therapy Designation this week from the U.S. Food and Drug Administration (FDA) for its Opdivo kidney-cancer test drug.Opdivo is a treatment candidate for use against advanced renal cell carcinoma (RCC). The designation comes after results of a CheckMate -025 Phase 3 study that ended in July after survivability endpoint goals were met.